CATX insider filings

Perspective Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen CATX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 13 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Lantheus Alpha Therapy, LLC — 10% owner & Lantheus Holdings, Inc. — 10% owner2—3 legs · 290,061 sh · $908,166—
Lantheus Alpha Therapy, LLC — 10% owner1—2 legs · 113,914 sh · $357,184—
Lantheus Holdings, Inc. — 10% owner2—2 legs · 113,914 sh · $357,184—
Williamson Robert F III — Director34 legs · 64,898 sh · $53,856——
Spoor Johan M. — Chief Executive Officer, Director11 leg · 47,000 sh · $37,943——
Puhlmann Markus — Chief Medical Officer12 legs · 41,000 sh · $34,544——
Morich Frank — Director22 legs · 30,000 sh · $29,002——
Woods Lori A — Director11 leg · 23,750 sh · $20,040——

Recent insider filings — Perspective Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-194Williamson Robert F III — DirectorPurchase (P): 15,000 @ $0.80EDGAR
2026-11-184Williamson Robert F III — DirectorPurchase (P): 25,000 @ $0.84EDGAR
2026-11-174Morich Frank — DirectorPurchase (P): 15,000 @ $0.94EDGAR
2026-11-164Woods Lori A — DirectorPurchase (P): 23,750 @ $0.84EDGAR
2026-11-164Williamson Robert F III — DirectorPurchase (P): 18,609 @ $0.84 · Purchase (P): 6,289 @ $0.84EDGAR
2026-11-164Morich Frank — DirectorPurchase (P): 15,000 @ $1.00EDGAR
2026-11-134Puhlmann Markus — Chief Medical OfficerPurchase (P): 6,000 @ $0.83 · Purchase (P): 35,000 @ $0.84EDGAR
2026-11-124Spoor Johan M. — Chief Executive Officer, DirectorPurchase (P): 47,000 @ $0.81EDGAR
2026-09-084Lantheus Alpha Therapy, LLC — 10% owner
Lantheus Holdings, Inc. — 10% owner
Sale (S): 80,783 @ $3.11 · Sale (S): 167,149 @ $3.15EDGAR
2026-09-044Lantheus Alpha Therapy, LLC — 10% owner
Lantheus Holdings, Inc. — 10% owner
Sale (S): 42,129 @ $3.11EDGAR
2026-09-044Lantheus Alpha Therapy, LLC — 10% ownerSale (S): 78,145 @ $3.14 · Sale (S): 35,769 @ $3.12EDGAR
2026-09-034Lantheus Holdings, Inc. — 10% ownerSale (S): 35,769 @ $3.12EDGAR
2026-09-024Lantheus Holdings, Inc. — 10% ownerSale (S): 78,145 @ $3.14EDGAR
2026-03-044Puhlmann Markus — Chief Medical OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2026-03-044Martinez Maria E — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-03-044Morich Frank — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-03-044Spoor Johan M. — Chief Executive Officer, DirectorGrant/award (A): 735,000 (derivative) @ $0EDGAR
2026-03-044Williamson Robert F III — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-03-044Woods Lori A — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-03-044Hunt Jonathan Robert — Chief Accounting OfficerGrant/award (A): 90,000 (derivative) @ $0EDGAR
2026-03-044HENSON HEIDI — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-11-174Hunt Jonathan Robert — Chief Accounting OfficerPurchase (P): 11,000 @ $2.03EDGAR
2025-11-144Williamson Robert F III — DirectorPurchase (P): 9,498 @ $2.10EDGAR
2025-09-054Martinez Maria E — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2025-09-054Sendek Joel — Chief Financial OfficerGrant/award (A): 600,000 (derivative) @ $0EDGAR
2025-04-014Graham Juan — Chief Financial OfficerPurchase (P): 33,333 @ $2.25EDGAR
2025-04-014Spoor Johan M. — Chief Executive Officer, DirectorPurchase (P): 22,026 @ $2.24 · Purchase (P): 4,650 @ $2.21EDGAR
2025-04-014Williamson Robert F III — DirectorPurchase (P): 22,192 @ $2.27 · Purchase (P): 38,145 @ $2.14EDGAR
2025-04-014Woods Lori A — DirectorPurchase (P): 23,475 @ $2.13EDGAR
2025-03-054Puhlmann Markus — Chief Medical OfficerGrant/award (A): 165,000 (derivative) @ $0EDGAR
2025-03-054Morich Frank — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-03-054Spoor Johan M. — Chief Executive Officer, DirectorGrant/award (A): 650,000 (derivative) @ $0EDGAR
2025-03-054Williamson Robert F III — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-03-054Woods Lori A — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-03-054Hunt Jonathan Robert — Chief Accounting OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2025-03-054HENSON HEIDI — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-01-074Graham Juan — Chief Financial OfficerGrant/award (A): 400,000 (derivative) @ $0EDGAR
2024-12-064HENSON HEIDI — DirectorPurchase (P): 25,975 @ $3.85EDGAR
2024-12-044Spoor Johan M. — CEO, DirectorPurchase (P): 8,000 @ $3.77EDGAR
2024-12-044/ASpoor Johan M. — CEO, DirectorHoldings only — no transactions reportedEDGAR
2024-12-044/AWilliamson Robert F III — DirectorHoldings only — no transactions reportedEDGAR
2024-11-274Williamson Robert F III — DirectorPurchase (P): 3,647 @ $3.62 · Purchase (P): 2,619 @ $3.67EDGAR
2024-11-274Hunt Jonathan Robert — Chief Financial OfficerPurchase (P): 400 @ $3.55 · Purchase (P): 29 @ $3.94 · Purchase (P): 2,400 @ $3.60 · Purchase (P): 10,000 @ $3.88EDGAR
2024-11-264Spoor Johan M. — CEO, DirectorPurchase (P): 14,500 @ $3.78 · Purchase (P): 5,400 @ $3.80 · Purchase (P): 6,600 @ $3.80EDGAR
2024-07-194Austin Mark John — VP Finance/Prin Fin&Acct OfficGrant/award (A): 34,500 (derivative) @ $0EDGAR
2024-06-244Spoor Johan M. — CEO, DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2024-06-244Williamson Robert F III — DirectorGrant/award (A): 23,000 (derivative) @ $0EDGAR
2024-06-244Woods Lori A — DirectorGrant/award (A): 23,000 (derivative) @ $0EDGAR
2024-06-244Hunt Jonathan Robert — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2024-06-244HENSON HEIDI — DirectorGrant/award (A): 23,000 (derivative) @ $0EDGAR

Recent 8-K events — Perspective Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-098-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-018-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-108-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CATX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs